The mitochondrial SIR2 related protein 2 (SIR2RP2) impacts Leishmania donovani growth and infectivity

Nimisha Mittal1, Rohini Muthuswami2, Rentala Madhubala1

  • 1School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.

Abstract

Insights

Leishmania donovani SIR2RP2, an enzyme, exhibits ADP-ribosyltransferase activity and is crucial for parasite survival and infectivity. Targeting this sirtuin offers a promising strategy for developing new visceral leishmaniasis drugs.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Biochemistry

Background:

  • Visceral leishmaniasis is caused by the protozoan parasite Leishmania donovani.
  • Existing drugs for leishmaniasis face challenges of toxicity and drug resistance.
  • Sirtuins (Silent Information Regulator proteins) are emerging as potential drug targets in kinetoplastids.

Purpose of the Study:

  • To functionally characterize the Leishmania donovani SIR2 related protein 2 (LdSIR2RP2).
  • To investigate the potential of LdSIR2RP2 as a drug target for visceral leishmaniasis.

Main Methods:

  • Recombinant LdSIR2RP2 was expressed, purified, and its enzymatic activities assessed.
  • Subcellular localization was determined using a GFP-tagged construct.
  • Gene deletion mutants (null mutants) were created and analyzed for growth, virulence, cell cycle, mitochondrial function, and drug sensitivity.

Main Results:

  • LdSIR2RP2 demonstrated NAD+-dependent ADP-ribosyltransferase activity but lacked deacetylase and desuccinylase functions.
  • The protein was localized to the mitochondrion in Leishmania promastigotes.
  • Null mutants exhibited restricted growth, G2/M phase cell cycle arrest, impaired mitochondrial function, and reduced infectivity.
  • Deletion of LdSIR2RP2 increased parasite sensitivity to sirtuin inhibitors, which also inhibited the recombinant enzyme's activity.

Conclusions:

  • LdSIR2RP2 is a functional enzyme with ADP-ribosyltransferase activity, essential for Leishmania donovani proliferation, mitochondrial function, and infectivity.
  • Targeting LdSIR2RP2, a sirtuin, presents a viable strategy for developing novel therapeutic interventions against visceral leishmaniasis.

Related Concept Videos

ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...